Drugs / Metotrexate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02036489 | Jan 2008 → Dec 2019 | acute lymphoblastic leukemia | PETHEMA Foundation | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Metotrexate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02036489 ↗ |
| Known as | Methotrexate | “Methotrexate (MTX ) : 12 mg” NCT02036489 ↗ |
| Known as | MTX | “Methotrexate (MTX ) : 12 mg” NCT02036489 ↗ |
| Route | Intrathecal | “Intrathecal chemotherapy * Methotrexate (MTX ) : 12 mg” NCT02036489 ↗ |